angiotensin ii has been researched along with DDD MPGNII in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (57.14) | 18.2507 |
2000's | 6 (42.86) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujigaki, Y; Fukasawa, H; Hishida, A; Huang, Y; Kitagawa, M; Misaki, T; Nakagawa, T; Nakamura, Y; Ohashi, N; Suzuki, F; Suzuki, H; Suzuki, S; Togawa, A; Yamamoto, T | 1 |
Fukuda, Y; Iino, Y; Ishizaki, M; Katayama, Y; Kawachi, H; Masuda, Y; Mii, A; Shimizu, A | 1 |
Kurogi, Y | 1 |
Hishida, A; Yasuda, H; Yonemura, K | 1 |
Gejyo, F; Iguchi, S; Iino, N; Ito, S; Karasawa, R; Kuriyama, H; Nakano, M; Narita, I; Nishi, S; Shimada, H; Ueno, M | 1 |
Ando, A; Fujibayashi, M; Fujiwara, Y; Imai, E; Kamada, T; Kaneko, T; Moriyama, T; Ueda, N; Xia, C | 1 |
Alcazar, R; Alonso, J; Egido, J; Gómez-Garre, D; Gómez-Guerrero, C; Gonzalez, E; López-Armada, MJ; Ruiz-Ortega, M | 1 |
Fujishima, M; Hirakata, H; Kanai, H; Kiyama, S; Okuda, S; Tomooka, S | 1 |
Chung, UG; Fujita, T; Hirakata, M; Hori, Y; Joki, N; Kaname, S; Katoh, T; Kurokawa, K; Noda, M; Okazaki, T; Takuwa, Y | 1 |
Abbate, M; Benigni, A; Bruzzi, I; Capitanio, M; Corna, D; Donadelli, R; Oldroyd, S; Remuzzi, G; Zoja, C | 1 |
Kanatsu, K; Kawai, C; Liang, P; Muso, E; Ono, T; Sasayama, S; Sekita, K; Shimada, T; Sugiyama, T; Takeuchi, E; Yashiro, M; Yoshida, H | 1 |
Border, WA; Noble, NA; Peters, H | 1 |
Kawachi, H; Kimura, H; Nakamura, T; Obata, J; Ohno, S; Shimizu, F; Yoshida, Y | 1 |
Helmchen, U; Stahl, RA; Thaiss, F; Wenzel, UO; Wolf, G | 1 |
1 review(s) available for angiotensin ii and DDD MPGNII
Article | Year |
---|---|
Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cell Division; Enzyme Inhibitors; Glomerular Mesangium; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Humans; Immunosuppressive Agents; Leukotriene D4; Platelet-Derived Growth Factor; Receptors, Angiotensin; Receptors, Estrogen | 2003 |
13 other study(ies) available for angiotensin ii and DDD MPGNII
Article | Year |
---|---|
Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Antilymphocyte Serum; Blood Pressure; Gene Expression; Glomerulonephritis, Membranoproliferative; Imidazoles; Kidney; Male; Proteinuria; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles | 2008 |
Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Becaplermin; Biomarkers; Blood Pressure; Cell Proliferation; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Imidazoles; Kidney Glomerulus; Male; Platelet-Derived Growth Factor; Proteinuria; Proto-Oncogene Proteins c-sis; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tetrazoles; Thy-1 Antigens | 2009 |
Distinct responses of membranoproliferative glomerulonephritis-related proteinuria to spironolactone with and without angiotensin II blockade.
Topics: Angiotensin II; Diuretics; Glomerulonephritis, Membranoproliferative; Humans; Proteinuria; Spironolactone | 2003 |
Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Complement System Proteins; Female; Glomerulonephritis, Membranoproliferative; Humans; Kidney Glomerulus; Lupus Nephritis; Prednisolone; Streptolysins | 2003 |
Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cell Division; Cells, Cultured; DNA; Gene Expression; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Interleukin-6; Kinetics; Mice; RNA, Messenger; Tetrazoles | 1995 |
Potential factors governing extracellular matrix production by mesangial cells: their relevance for the pathogenesis of IgA nephropathy.
Topics: Angiotensin II; Animals; Cell Division; Collagen; Endothelins; Extracellular Matrix; Extracellular Matrix Proteins; Fibronectins; Glomerular Mesangium; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Humans; Immunoglobulin A; Immunoglobulin G; Interleukin-6; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 1995 |
Effects of endothelin and angiotensin II on renal hemodynamics in experimental mesangial proliferative nephritis.
Topics: Angiotensin II; Animals; Antilymphocyte Serum; Disease Models, Animal; Endothelins; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Hypertension, Renal; Rats; Rats, Wistar; Renal Circulation | 1993 |
Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells.
Topics: Angiotensin II; Animals; Calcium Channel Blockers; Cells, Cultured; Collagen; Culture Media, Conditioned; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Fibronectins; Gene Expression; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Protein Kinase C; Protein-Tyrosine Kinases; Rats; RNA, Messenger; Stress, Mechanical; Transforming Growth Factor beta | 1997 |
Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antilymphocyte Serum; Blood Pressure; Cell Division; Creatinine; Glomerulonephritis, Membranoproliferative; Immunoglobulin G; Kidney; Kidney Glomerulus; Lisinopril; Macrophages; Male; Monocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 1998 |
Mesangiolytic glomerulopathy in severe congestive heart failure.
Topics: Adult; Aged; Angiotensin II; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Capillaries; Female; Glomerulonephritis, Membranoproliferative; Heart Failure; Hematocrit; Humans; Hypertension; Kidney Glomerulus; Macrophages; Male; Middle Aged; Oxygen; Periodic Acid-Schiff Reaction | 1998 |
Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Eating; Enalapril; Fibronectins; Fibrosis; Glomerulonephritis, Membranoproliferative; Kidney; Losartan; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 1998 |
Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Cilazapril; Collagen; Disease Models, Animal; Glomerulonephritis, Membranoproliferative; Hydralazine; Kidney Failure, Chronic; Male; Proteinuria; Rats; Rats, Wistar; Renal Circulation; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta | 1999 |
Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis.
Topics: Angiotensin II; Animals; Cell Cycle Proteins; Cell Division; Complement C3; Cyclin-Dependent Kinase Inhibitor p27; Extracellular Matrix; Glomerulonephritis, Membranoproliferative; Immunoglobulin G; Infusion Pumps; Kidney Glomerulus; Macrophages; Male; Monocytes; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Transforming Growth Factor beta; Tumor Suppressor Proteins; Vasoconstrictor Agents | 2002 |